|
1
|
Ji AX, Chu A, Nielsen TK, Benlekbir S,
Rubinstein JL and Privé GG: Structural insights into KCTD protein
assembly and cullin3 recognition. J Mol Biol. 428:92–107. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Resendes BL, Kuo SF, Robertson NG, Giersch
AB, Honrubia D, Ohara O, Adams JC and Morton CC: Isolation from
cochlea of a novel human intronless gene with predominant fetal
expression. J Assoc Res Otolaryngol. 5:185–202. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schwenk J, Metz M, Zolles G, Turecek R,
Fritzius T, Bildl W, Tarusawa E, Kulik A, Unger A, Ivankova K, et
al: Native GABA(B) receptors are heteromultimers with a family of
auxiliary subunits. Nature. 465:231–235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turecek R, Schwenk J, Fritzius T, Ivankova
K, Zolles G, Adelfinger L, Jacquier V, Besseyrias V, Gassmann M,
Schulte U, et al: Auxiliary GABAB receptor subunits
uncouple G protein βγ subunits from effector channels to induce
desensitization. Neuron. 82:1032–1044. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cathomas F, Stegen M, Sigrist H, Schmid L,
Seifritz E, Gassmann M, Bettler B and Pryce CR: Altered
emotionality and neuronal excitability in mice lacking KCTD12, an
auxiliary subunit of GABAB receptors associated with
mood disorders. Transl Psychiatry. 5:e5102015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suehara Y, Kondo T, Seki K, Shibata T,
Fujii K, Gotoh M, Hasegawa T, Shimada Y, Sasako M, Shimoda T, et
al: Pfetin as a prognostic biomarker of gastrointestinal stromal
tumors revealed by proteomics. Clin Cancer Res. 14:1707–1717. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kubota D, Mukaihara K, Yoshida A, Suehara
Y, Saito T, Okubo T, Gotoh M, Orita H, Tsuda H, Kaneko K, et al:
The prognostic value of pfetin: A validation study in
gastrointestinal stromal tumors using a commercially available
antibody. Jpn J Clin Oncol. 43:669–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hasegawa T, Asanuma H, Ogino J, Hirohashi
Y, Shinomura Y, Iwaki H, Kikuchi H and Kondo T: Use of potassium
channel tetramerization domain-containing 12 as a biomarker for
diagnosis and prognosis of gastrointestinal stromal tumor. Hum
Pathol. 44:1271–1277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Duan T, Wang X, Zhang RH, Zhang M,
Wang S, Wang F, Wu Y, Huang H and Kang T: KCTD12 regulates
colorectal cancer cell stemness through the ERK pathway. Sci Rep.
6:204602016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chattopadhyay C, Kim DW, Gombos DS, Oba J,
Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, et
al: Uveal melanoma: From diagnosis to treatment and the science in
between. Cancer. 122:2299–2312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang AE, Karnell LH and Menck HR: The
American College of Surgeons Commission on Cancer and the American
Cancer Society: The National Cancer Data Base report on cutaneous
and noncutaneous melanoma: A summary of 84,836 cases from the past
decade. Cancer. 83:1664–1678. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eskelin S and Kivelä T: Mode of
presentation and time to treatment of uveal melanoma in Finland. Br
J Ophthalmol. 86:333–338. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shields CL and Shields JA: Ocular
melanoma: Relatively rare but requiring respect. Clin Dermatol.
27:122–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh AD, Turell ME and Topham AK: Uveal
melanoma: Trends in incidence, treatment, and survival.
Ophthalmology. 118:1881–1885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh AD and Topham A: Survival rates with
uveal melanoma in the United States: 1973–1997. Ophthalmology.
110:956–961. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gill HS and Char DH: Uveal melanoma
prognostication: From lesion size and cell type to molecular class.
Can J Ophthalmol. 47:246–253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patel SP: Latest developments in the
biology and management of uveal melanoma. Curr Oncol Rep.
15:509–516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harbour JW, Roberson ED, Anbunathan H,
Onken MD, Worley LA and Bowcock AM: Recurrent mutations at codon
625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet.
45:133–135. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Field MG and Harbour JW: Recent
developments in prognostic and predictive testing in uveal
melanoma. Curr Opin Ophthalmol. 25:234–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu FX, Zhang K and Guan KL: YAP as
oncotarget in uveal melanoma. Oncoscience. 1:480–481. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao L, Ding J, Dong L, Zhao J, Su J, Wang
L, Sui Y, Zhao T, Wang F, Jin J, et al: Negative regulation of
p21Waf1/Cip1 by human INO80 chromatin remodeling complex
is implicated in cell cycle phase G2/M arrest and abnormal
chromosome stability. PLoS One. 10:e01374112015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Xiang Y and Sun G: The KCTD family
of proteins: Structure, function, disease relevance. Cell Biosci.
3:452013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Canettieri G, Di Marcotullio L, Greco A,
Coni S, Antonucci L, Infante P, Pietrosanti L, De Smaele E,
Ferretti E, Miele E, et al: Histone deacetylase and
Cullin3-RENKCTD11 ubiquitin ligase interplay regulates
Hedgehog signalling through Gli acetylation. Nat Cell Biol.
12:132–142. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Staropoli JF, Karaa A, Lim ET, Kirby A,
Elbalalesy N, Romansky SG, Leydiker KB, Coppel SH, Barone R, Xin W,
et al: A homozygous mutation in KCTD7 links neuronal ceroid
lipofuscinosis to the ubiquitin-proteasome system. Am J Hum Genet.
91:202–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mancarelli MM, Zazzeroni F, Ciccocioppo L,
Capece D, Po A, Murgo S, Di Camillo R, Rinaldi C, Ferretti E,
Gulino A, et al: The tumor suppressor gene KCTD11REN is
regulated by Sp1 and methylation and its expression is reduced in
tumors. Mol Cancer. 9:1722010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Faryna M, Konermann C, Aulmann S, Bermejo
JL, Brugger M, Diederichs S, Rom J, Weichenhan D, Claus R, Rehli M,
et al: Genome-wide methylation screen in low-grade breast cancer
identifies novel epigenetically altered genes as potential
biomarkers for tumor diagnosis. FASEB J. 26:4937–4950. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu Q, Deng F, Qin Y, Zhao Z, Wu Z, Xing Z,
Ji A and Wang QJ: Long non-coding RNA regulation of
epithelial-mesenchymal transition in cancer metastasis. Cell Death
Dis. 7:e22542016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
